- ►nih.gov JB Hassell, EL Lamoureux, JE Keeffe - British Journal of Ophthalmology, 2006 - bjo.bmj.com Results: The mean age of the 106 participants (66% female) was 83.6 years (range
64–98). One quarter had mild vision impairment, (VA<6/12–6/18) and 75% had
moderate or severely impaired vision. Participants reported from at least ... Cited by 40 - Related articles - BL Direct - All 6 versions
D Pauleikhoff - Retina, 2005 - journals.lww.com Supported by Novartis Pharma AG and QLT, Inc., for the author as an investigator
in the Verteporfin In Photodynamic Therapy Trial and other verteporfin clinical
studies. The author has no proprietary, commercial, or financial interest ... Cited by 39 - Related articles - BL Direct - All 4 versions
GC Brown, MM Brown, S Sharma, JD Stein, Z … - Transactions of the American Ophthalmological Society, 2005 - pubmedcentral.nih.gov From the Center for Value-Based Medicine, Flourtown, Pennsylvania (Dr G. Brown,
Dr M. Brown, Dr Sharma, Dr Stein, Mr Roth, Mr Campanella, Dr Beauchamp); the
Department of Ophthalmology, University of Pennsylvania School of Medicine, ... Cited by 39 - Related articles - BL Direct - All 6 versions
GH Berdeaux, JP Nordmann, E Colin, B … - American journal of ophthalmology, 2005 - Elsevier Best eye VA was 0.34 on average, with VA > 20/40 in 43.0% of patients. Worst eye
VA was 0.85 on average, with VA > 20/200 in 32.5% of patients. VA was not linked
to general health and ocular pain scores. General Vision, Near Activities, ... Cited by 35 - Related articles - All 12 versions
DR Globe, J Wu, SP Azen, R Varma - Ophthalmology, 2004 - Elsevier To assess the association between presenting binocular visual acuity (VA) and
self-reported visual function as measured by the 25-item National Eye Institute
Visual Function Questionnaire (NEI-VFQ-25). ... A population-based, ... Cited by 33 - Related articles - All 3 versions
GC Brown, MM Brown, J Campanella, GR … - American journal of ophthalmology, 2005 - Elsevier Five-year visual acuity data from the TAP (Treatment of Age-related Macular
Degeneration With Photodynamic Therapy) Investigation were modeled into a
12-year, value-based, reference case, cost-utility model utilizing year ... Cited by 34 - Related articles - All 5 versions
J Mitchell, C Bradley - Health and quality of life outcomes, 2006 - biomedcentral.com Address: Department of Psychology, Royal Holloway, University of London, Egham,
Surrey, TW20 0EX, UK Email: Jan Mitchell* - j.mitchell@rhul.ac.uk; Clare Bradley
- c.bradley@rhul.ac.uk * Corresponding author ... Abstract Background: ... Cited by 30 - Related articles - View as HTML - All 9 versions
M Kuppermann, RF Nease Jr, E Gates, LA … - Prenatal diagnosis, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 24 - Related articles - BL Direct - All 4 versions
- ►nih.gov - Free from Publisher V Gupta, G Srinivasan, SS Mei, G Gazzard, R … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Methods: Utility values of 105 consecutive patients with primary glaucoma of at
least 12 months' duration were evaluated in a cross sectional study. Utility
values were ascertained in five groups using both the time-trade off and ... Cited by 18 - Related articles - BL Direct - All 9 versions
JM Scanlan, JE Cuddeford - Rehabilitation, 2004 - afb.org Age-related macular degeneration (ARMD) is the leading cause of the loss of
central vision in the elderly (Brody et al., 2002; Daniel, 2002; Verezen,
Völker-Dieben, & Hoyng, 1996). This loss of vision is irreversible and ... Cited by 17 - Related articles - BL Direct - All 2 versions
